42nd AGM notice and FY26 annual report enclosed

Revenue declinedEBITDA margin compressionResults View source PDF Explain this filing

NILE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1470.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.2% vs market

Industrial Minerals peers, median of 13sector-1.0%+0.2% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.2 pts more than its Industrial Minerals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.4-1.2-1.0+0.2

Next day

+0.7+0.9-0.3-0.5+1.1

+0.2+0.8-0.6-0.5+0.7

-1.4+0.6-2.0-0.9-0.5

-1.5+0.7-2.2-2.0+0.5

-2.6-2.6+0.0-5.0+2.4

-1.4-1.9+0.5-3.5+2.1

15d

-12.9-0.6-12.4-5.6-7.3

-13.9-1.0-12.9-8.3-5.6

—————

UpDownMarket · Nifty Microcap 250Sector · Industrial Minerals peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NILE Limited filed its 42nd AGM notice and FY 2025-26 annual report. AGM set for September 30, 2026 via video conferencing. Turnover declined to Rs.806.33 Cr from Rs.837.62 Cr; net profit fell to Rs.22.72 Cr from Rs.31.57 Cr. Interim dividend of Rs.5 per share (up from Rs.4) up for confirmation. Statutory auditor to change to M. Bhaskara Rao and Co for 5 years from FY27. MD Sandeep Vuyyuru Ramesh reappointed for 3 years with salary of Rs.4 lakh per month plus 3 percent commission on net profits.

Likely market impact

Earnings declined sharply but interim dividend raised to Rs.5 per share. Auditor change and MD reappointment are routine corporate items.